Palvella Therapeutics (PVLA) Misses Q2 EPS by 36c
Tweet
Share
E-mailGet Alerts PVLA Hot Sheet
Join SI Premium – FREE
Palvella Therapeutics (NASDAQ: PVLA) reported Q2 EPS of ($1.52), $0.36 worse than the analyst estimate of ($1.16).
For earnings history and earnings-related data on Palvella Therapeutics (PVLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Honeywell Aerospace completes exchange of $16B in unregistered notes
- Jefferies Upgrades Five Below (FIVE) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
